According to my opinion there are lots of gaps in our knowledge regarding antipsychotic use in children. FDA approvals are sometimes hard to follow or distinguish. For example, what are the differences between: Hyperactivity (not ADHD), Severe behavioral problems - Chlorpromazine FDA indications,
Agitation - Droperidol FDA indication,
Severe childhood behavioral problems – Haloperidol FDA indications,
Irritability Associated with autistic disorder Aripiprazole FDA indications in Children (6–17 years);
Irritability associated with autism Risperidone FDA indication in Children (5–16 years) ?
What is difference between Aripiprazole and Risperidone which explains age range 6-17 vs 5-16?
How to make clear distinction between agitation, severe behavioral problems, irritability, agitation?
And how come that the older antipsychotic Chlorpromazine from first generation class has the highest number of FDA approved indications in children, although SGA found to be safer than FGA?
Yes, I agree - lots of gaps in knowledge. A different approach that may be of interest is reflected in the book: Young People Hearing Voices (2013), by Drs. Sandra Escher & Marcus Romme.
- Badges
- Science method